The minimum inhibitory concentration and minimum bactericidal concentration of BAL9141 against 150 clinical isolates of gram-negative bacteria were determined and compared to those of cefepime and ceftriaxone. BAL9141 exhibited comparable activity to cefepime and ceftriaxone against Haemophilus influenzae, Klebsiella pneumoniae, and extended-spectrum β-lactamase nonproducing Enterobacter cloacae, and comparable activity to cefepime against Pseudomonas aeruginosa.
|Original language||English (US)|
|Number of pages||3|
|Journal||Diagnostic Microbiology and Infectious Disease|
|State||Published - Jan 2004|
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases